Atrás
Rango del Día
$1.64
$1.67
Rango de 52 Semanas
$1.24
$3.34
Volumen
12,000
Promedio 50D / 200D
$1.92
/
$2.04
Cierre Anterior
$1.67
Historial de Precios
Tendencias Financieras
Comparación con Pares
vs mediana del sector Healthcare (627 pares)
| Métrica | Acción | Mediana del Sector |
|---|---|---|
| P/E | -10.9 | 0.4 |
| P/B | 3.4 | 2.9 |
| ROE % | -27.7 | 3.7 |
| Net Margin % | -64.9 | 3.9 |
| Rev Growth 5Y % | 13.8 | 10.0 |
| D/E | 0.1 | 0.2 |
Precio Objetivo de Analistas
No hay cobertura de analistas disponible
Estimaciones de Ganancias
| Período | EPS Est. | Ingresos Est. | Analistas |
|---|---|---|---|
| FY2030 |
$0.10
$0.09 – $0.12
|
700 M | 1 |
| FY2029 |
$0.04
$0.03 – $0.05
|
530 M | 1 |
| FY2028 |
-$0.02
-$0.02 – -$0.01
|
430 M | 1 |
Puntos Clave
Revenue grew 13.76% annually over 5 years — strong growth
Debt/Equity of 0.09 — conservative balance sheet
Negative free cash flow of -66.29M
Revenue growth is accelerating — 1Y growth exceeds 5Y average by 8.44%
Capital efficient — spends only 1.56% of revenue on capex
Crecimiento
Revenue Growth (5Y)
13.76%
Revenue (1Y)22.20%
Earnings (1Y)N/A
FCF Growth (3Y)N/A
Calidad
Return on Equity
-27.66%
ROIC-23.07%
Net Margin-64.85%
Op. Margin-69.36%
Seguridad
Debt / Equity
0.09
Current Ratio3.56
Interest Coverage-55.46
Valoración
P/E Ratio
-10.92
P/B Ratio3.42
EV/EBITDAN/A
Dividend Yield0.00%
All Fundamental Metrics
| Growth | |||
| Revenue Growth (1Y) | 22.20% | Revenue Growth (3Y) | 14.87% |
| Earnings Growth (1Y) | N/A | Earnings Growth (3Y) | N/A |
| Revenue Growth (5Y) | 13.76% | Earnings Growth (5Y) | N/A |
| Profitability | |||
| Revenue (TTM) | 223.86M | Net Income (TTM) | -145.18M |
| ROE | -27.66% | ROA | -23.33% |
| Gross Margin | 58.64% | Operating Margin | -69.36% |
| Net Margin | -64.85% | Free Cash Flow (TTM) | -66.29M |
| ROIC | -23.07% | FCF Growth (3Y) | N/A |
| Safety | |||
| Debt / Equity | 0.09 | Current Ratio | 3.56 |
| Interest Coverage | -55.46 | Dividend Yield | 0.00% |
| Valuation | |||
| P/E Ratio | -10.92 | P/B Ratio | 3.42 |
| P/S Ratio | 7.08 | PEG Ratio | 1.35 |
| EV/EBITDA | N/A | Dividend Yield | 0.00% |
| Market Cap | 1.59B | Enterprise Value | 1.45B |
Income Statement
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenue | 223.86M | 183.19M | 169.67M | 198.60M | 133.66M |
| Net Income | -145.18M | -146.19M | -154.51M | -91.03M | -167.61M |
| EPS (Diluted) | -0.15 | -0.16 | -0.19 | -0.11 | -0.20 |
| Gross Profit | 131.28M | 105.40M | 90.48M | 123.81M | 73.20M |
| Operating Income | -155.27M | -152.33M | -168.61M | -98.48M | -164.53M |
Balance Sheet
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Total Assets | 622.40M | 742.05M | 777.06M | 823.89M | 841.87M |
| Total Liabilities | 159.17M | 155.71M | 133.21M | 130.33M | 137.89M |
| Shareholders' Equity | 463.22M | 586.34M | 643.85M | 693.56M | 703.98M |
| Total Debt | 41.49M | 45.96M | 41.66M | 34.10M | 24.80M |
| Cash & Equivalents | 181.07M | 199.52M | 220.54M | 356.78M | 487.84M |
| Current Assets | 419.93M | 520.10M | 447.18M | 638.00M | 750.61M |
| Current Liabilities | 117.98M | 111.49M | 89.20M | 91.54M | 105.05M |